Prevalence of cancer alarm symptoms: A population-based cross-sectional study

Figures & data

Figure 1. Study sample.

Table I. Age- and sex-specific prevalences of cancer alarm symptoms.

	Felt a lump in your breast? One-year prevalence					Seen blood in your stools? One-year prevalence					Seen blood in your urine? One year prevalence					Coughed for more the six weeks? One year prevalence
	Women		Men		Total, weighted	Women		Men		Total, weighted	Women		Men		Total, weighted	Women		Men		Total, weighted
Age group (years)	n		n			n		n			n		n			n		n
20–39	42	7.0 (5.1–9.3)	4	0.8 (.2–2.0)	4.1 (1.2–3.0)	44	7.3 (5.4 to 9.7)	44	8.8 (6.4–11.6)	8.0 (6.5–9.7)	17	2.8 (1.7−4.5)	4	0.8 (.2–2.0)	1.9 (1.2 to 2.9)	36	6.0 (4.2–8.2)	24	4.8 (3.1–7.0)	5.4 (4.2–6.9)
40–59	223	6.6 (5.8–7.5)	36	1.2 (.8–1.6)	4.1 (3.7 to 4.7)	173	5.1 (4.4 to 5.9)	234	7.7 (6.–8.7)	6.3 (5.7–6.9)	74	2.2 (1.7–2.7)	46	1.5 (1.1–2.0)	1.9 (1.6 to 2.3)	251	7.4 (6.6 to 8.4)	190	6.3 (5.4–7.2)	6.9 (6.3–7.6)
60–79	68	2.5 (1.9–3.1)	21	0.8 (.5–1.2)	1.7 (1.4 to 2.1)	81	3.0 (2.4 to 3.7)	115	4.4 (3.6–5.2)	3.6 (3.2–4.2)	56	2.1 (1.6–2.7)	86	3.3 (2.6–4.0)	2.6 (2.2 to 3.1)	216	7.9 (6.9–9.0)	183	7.0 (6.0–8.0)	7.5 (6.8–8.2)
80–99	12	2.3 (1.2–3.9)	5	1.3 (.4–3.0)	1.9 (1.2 to 3.0)	13	2.5 (1.3 to 4.2)	9	2.3 (1.1–4.4)	2.4 (1.6–3.6)	11	2.2 (1.0 to 3,7)	13	3.4 (1.8–5.7)	2.6 (1.8 to 3.9)	25	4.7 (3.1–6.9)	15	3.9 (2.2–6.4)	4.4 (3.2–5.9)
Total, both gender weighted	3.3 (2.9–3.7)					5.7 (5.2–6.3)					3.3 (2.9–3.7)					6.5 (6.1–7.5)

Note: Figures are percentages (95% CI) unless stated otherwise.

Table II. Sex- and age-specific description of how many alarm symptoms of cancer the sample have experienced within the last year.

Age group (years)	Gender	n	n	Have not experienced any symptoms	n	Have experienced one symptom	n	Have experienced two symptoms	n	Have experienced three or more symptoms
20–39	Women	603	483	80.1 (76.7–83.2)	102	16.9 (14.0–20.2)	17	2.8 (1.7–4.5)	1	0.2 (0.0–0.9)
	Men	502	431	85.9 (82.5–88.8)	66	13.1 (10.3–16.4)	5	1.0 (0.3–2.3)	0	0 (0–0.7)*
40–59	Women	3379	2742	81.1 (79.8–82.5)	562	16.6 (15.4–17.9)	66	2.0 (1.5–2.5)	9	0.3 (0.1–0.5)
	Men	3024	2571	85.0 (83.7–86.3)	408	13.5 (12.3–14.8)	39	1.3 (0.9–1.8)	6	0.2 (0.1–0.4)
60–79	Women	2733	2354	86.1 (84.8–87.4)	341	12.5 (11.3–13.8)	34	1.3 (0.9–1.7)	4	0.1 (0.0–0.4)
	Men	2624	2277	86.8 (85.4–88.0)	293	11.2 (10.0–12.4)	50	1.9 (1.4–2.5)	4	0.2 (0.0–0.4)
80–99	Women	528	474	89.8 (86.9–92.2)	47	8.9 (6.6–11.7)	7	1.3 (0.5–2.7)	0	0 (0–0.7)*
	Men	384	347	90.4 (87.0–93.1)	33	8.6 (6.0–11.9)	3	0.8 (0.2–2.3)	1	0.3 (0.0–1.4)
Total	Women	7243	5912	83.6 (82.7–84.4)	1052	14.8 (14.0–15.7)	124	1.7 (1.4–2.1)	14	0.2 (0.1–0.3)
	Men	6534	5489	86.1 (85.2–86.9)	800	12.5 (11.7–13.3)	97	1.5 (1.2–1.8)	9	0.2 (0.1–0.3)
Total weighted	Women		82.6 (81.5–83.6)		15.3 (14.3–16.3)		2.0 (1.5–2.4)		0.2 (0.1–0.3)
	Men		85.8 (84.7–86.9)		12.7 (11.6–13.7)		1.4 (1.1–1.7)		0.1 (0.1–0.2)
Total, weighted estimate	Both genders		84.3 (83.6–85.1)		13.8 (13.1–14.6)		1.7 (1.4–2.0)		1.6 (0.1–0.3)

Notes: Figures are percentages (95% CI) unless stated otherwise. *One-sided ANOVA.